Examination of Regional Lymph Nodes by Sentinel Node Biopsy and Molecular Analysis Provides New Staging Facilities in Primary Cutaneous Melanoma
Blaheta H-J, Ellwanger U, Schittek B, Sotlar K, Maczey E, Breuninger H, Thelen MH, Bueltmann B, Rassner G, Garbe C
J Invest Dermatol. 2000;114:637-642
Blaheta et al conducted a prospective cohort study on 116 patients with newly diagnosed primary cutaneous melanoma greater than or equal to 0.9 mm in Breslow depth. No patients showed evidence of metastatic disease and all underwent sentinel lymph node (SLN) biopsy.
Connors J, Smoller B, Dinehart S. Sentinel Node Biopsy for Melanoma: What Is the Evidence? Arch Dermatol. 2001;137(9):1228–1231. doi:10.1001/archderm.137.9.1228
Artificial Intelligence Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.